Cited by 456Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin EffectsMitochondrial Function and Pathology

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults

Open access

Rossman, Matthew J., Santos-Parker, Jessica R., Steward, Chelsea A.C., Bispham, Nina Z., Cuevas, Lauren M., Rosenberg, Hannah L., Woodward, Kayla A., Chonchol, Michel, Gioscia-Ryan, Rachel A., Murphy, Michael P., Seals, Douglas R.·2018·Hypertension

DOI 10.1161/hypertensionaha.117.10787PMC PMC5945293

Open this paper in CoChat — free account Open PDF

Abstract

Excess reactive oxygen species production by mitochondria is a key mechanism of age-related vascular dysfunction. Our laboratory has shown that supplementation with the mitochondrial-targeted antioxidant MitoQ improves vascular endothelial function by reducing mitochondrial reactive oxygen species and ameliorates arterial stiffening in old mice, but the effects in humans are unknown. Here, we sought to translate our preclinical findings to humans and determine the safety and efficacy of MitoQ. Twenty healthy older adults (60–79 years) with impaired endothelial function (brachial artery flow–mediated dilation <6%) underwent 6 weeks of oral supplementation with MitoQ (20 mg/d) or placebo in a randomized, placebo-controlled, double-blind, crossover design study. MitoQ was well tolerated, and plasma MitoQ was higher after the treatment versus placebo period ( P <0.05). Brachial artery flow–mediated dilation was 42% higher after MitoQ versus placebo ( P <0.05); the improvement was associated with amelioration of mitochondrial reactive oxygen species–related suppression of endothelial function (assessed as the increase in flow-mediated dilation with acute, supratherapeutic MitoQ [160 mg] administration; n=9; P <0.05). Aortic stiffness (carotid–femoral pulse wave velocity) was lower after MitoQ versus placebo ( P <0.05) in participants with elevated baseline levels (carotid–femoral pulse wave velocity >7.60 m/s; n=11). Plasma oxidized LDL (low-density lipoprotein), a marker of oxidative stress, also was lower after MitoQ versus placebo ( P <0.05). Participant characteristics, endothelium-independent dilation (sublingual nitroglycerin), and circulating markers of inflammation were not different (all P >0.1). These findings in humans extend earlier preclinical observations and suggest that MitoQ and other therapeutic strategies targeting mitochondrial reactive oxygen species may hold promise for treating age-related vascular dysfunction. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT02597023.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.117.10787

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Anthropometric Standardization Reference Manual
Lohman, T. J., Roache, A. F., & Martorell, R. (1992) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199208000-00020 · Cited by 2,764
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part I: Aging Arteries: A “Set Up” for Vascular Disease
Lakatta, E. G., & Levy, D. (2003) · Circulation · doi:10.1161/01.cir.0000048892.83521.58 · Cited by 2,244
Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study
Mitchell, G. F., Hwang, S.-J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., Vita, J. A., Levy, D., & Benjamin, E. J. (2010) · Circulation · doi:10.1161/circulationaha.109.886655 · Cited by 2,225
Long-term weight loss maintenance
Wing, R. R., & Phelan, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.222s · Cited by 1,941
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., Boutouyrie, P., Cameron, J., Chen, C.-H., Cruickshank, J. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.063 · Cited by 1,835
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters?
Hofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · PubMed · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness
Townsend, R. R., Wilkinson, I. B., Schiffrin, E. L., Avolio, A. P., Chirinos, J. A., Cockcroft, J. R., Heffernan, K. S., Lakatta, E. G., McEniery, C. M., Mitchell, G. F., et al. (2015) · Hypertension · doi:10.1161/hyp.0000000000000033 · Cited by 1,527

Show all 42 references

Sorted by citations

Mitochondrial dysfunction: mechanisms and advances in therapy
Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,382
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 1,016
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 846
Self-citation
Aging and age‐related diseases: from mechanisms to therapeutic strategies
Li, Z., Zhang, Z., Ren, Y., Wang, Y., Fang, J., Yue, H., Ma, S., & Guan, F. (2021) · Biogerontology · doi:10.1007/s10522-021-09910-5 · Cited by 702
Oxidative Stress and Hypertension
Griendling, K. K., Camargo, L. L., Rios, F. J. O., Alves-Lopes, R., Montezano, A. C. I., & Touyz, R. M. (2021) · Circulation Research · doi:10.1161/circresaha.121.318063 · Cited by 618
Mechanisms of Vascular Aging, A Geroscience Perspective
Ungvari, Z. I., Tarantini, S., Sorond, F. A., Merkely, B. P., & Csiszár, A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.061 · Cited by 334
Gut bacteria signaling to mitochondria in intestinal inflammation and cancer
Jackson, D. N., & Theiss, A. L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1592421 · Cited by 312
Sex differences in mechanisms of arterial stiffness
DuPont, J. J., Kenney, R. M., Patel, A. R., & Jaffe, I. Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14624 · Cited by 305
Trimethylamine-N-Oxide Promotes Age-Related Vascular Oxidative Stress and Endothelial Dysfunction in Mice and Healthy Humans
Brunt, V. E., Gioscia‐Ryan, R. A., Casso, A. G., VanDongen, N. S., Ziemba, B. P., Sapinsley, Z. J., Richey, J. J., Zigler, M. C., Neilson, A. P., Davy, K. P., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14759 · Cited by 294
Self-citation
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 305
Oxidative Stress: A Unifying Paradigm in Hypertension
Touyz, R. M., Rios, F. J. O., Alves-Lopes, R., Neves, K. B., Camargo, L. L., & Montezano, A. C. I. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.081 · Cited by 286
Structural Features of Small Molecule Antioxidants and Strategic Modifications to Improve Potential Bioactivity
Charlton, N. C., Mastyugin, M., Török, B., & Török, M. (2023) · Molecules · doi:10.3390/molecules28031057 · Cited by 292
Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary
Umehara, T., Winstanley, Y. E., Andreas, E., Morimoto, A., Williams, E. J., Smith, K. M., Carroll, J., Febbraio, M. A., Shimada, M., Russell, D. L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn4564 · Cited by 250
Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment
Wang, Y., Cheng, H., Wang, T., Zhang, K., Zhang, Y., & Kang, X. (2023) · Cell Proliferation · doi:10.1111/cpr.13448 · Cited by 243
The Role of Taurine in Mitochondria Health: More Than Just an Antioxidant
Jong, C. J., Sandal, P., & Schaffer, S. W. (2021) · Molecules · doi:10.3390/molecules26164913 · Cited by 241
Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities
Kiyuna, L. A., Albuquerque, R. P. E., Chen, C., Mochly‐Rosen, D., & Ferreira, J. C. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.019 · Cited by 231
The role of mitochondrial dynamics in cardiovascular diseases
Forte, M., Schirone, L., Ameri, P., Basso, C., Catalucci, D., Modica, J., Chimenti, C., Crotti, L., Frati, G., Rubattu, S. D., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15068 · Cited by 227
Mechanisms of Endothelial Dysfunction in Pre-eclampsia and Gestational Diabetes Mellitus: Windows Into Future Cardiometabolic Health?
McElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 236
Mitochondria-Targeted Drugs
Zinovkin, R. A., & Zamyatnin, A. A. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666181127151059 · Cited by 209
Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment
Jiang, Q., Yin, J., Chen, J., Ma, X., Wu, M., Liu, G., Kang, Y., Tan, B., & Yin, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8837893 · Cited by 212
Mitochondrial dynamics and transport in Alzheimer's disease
Flannery, P. J., & Trushina, E. V. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.009 · Cited by 203
Mitochondrial Potentiation Ameliorates Age-Related Heterogeneity in Hematopoietic Stem Cell Function
Mansell, E., Sigurðsson, V., Deltcheva, E. M., Brown, J., James, C. T., Miharada, K., Soneji, S., Larsson, J. T., & Enver, T. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.09.018 · Cited by 187
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Byrne, N. J., Rajasekaran, N. S., Abel, E. D., & Bugger, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.046 · Cited by 179
NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Liu, P., Lu, Z., Liu, L., Li, R., Liang, Z., Shen, M., Han, X., Ren, D., Ji, M., Yuan, S., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152925 · Cited by 174
Cold‐induced cutaneous vasoconstriction in humans: Function, dysfunction and the distinctly counterproductive
Alba, B. K., Castellani, J. W., & Charkoudian, N. (2019) · Experimental Physiology · doi:10.1113/ep087718 · Cited by 169
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants
Granata, S., Votrico, V., Spadaccino, F., Catalano, V., Netti, G. S., Ranieri, E., Stallone, G., & Zaza, G. (2022) · Antioxidants · doi:10.3390/antiox11040769 · Cited by 158
Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials
Nguyen, B. Y., Ruiz‐Velasco, A., Bùi, T. A., Collins, L., Wang, X., & Liu, W. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14431 · Cited by 156
Reactive oxygen species in hypertension
Camargo, L. L., Rios, F. J. O., Montezano, A. C. I., & Touyz, R. M. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01062-6 · Cited by 162
Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation
Totoń‐Żurańska, J., Mikolajczyk, T. P., Saju, B., & Guzik, T. J. (2024) · Clinical Science · doi:10.1042/cs20220797 · Cited by 156
Antioxidants and Reactive Oxygen Species: Shaping Human Health and Disease Outcomes
Manful, C. F., Fordjour, E., Subramaniam, D., Sey, A. A., Abbey, L., & Thomas, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157520 · Cited by 193
Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases
Kirkman, D. L., Robinson, A. T., Rossman, M. J., Seals, D. R., & Edwards, D. G. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00917.2020 · Cited by 150
Self-citation
Mitochondrial dysfunction and mitochondrial therapies in heart failure
Wu, C., Zhang, Z., Zhang, W., & Liu, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106038 · Cited by 148
Unlocking the Secrets of Mitochondria in the Cardiovascular System
Tian, R., Colucci, W. S., Arany, Z. P., Bachschmid, M. M., Ballinger, S. W., Boudina, S., Bruce, J. E., Busija, D. W., Dikalov, S., Dorn, G. W., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040551 · Cited by 135
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
Yamada, Y., Satrialdi, S., Hibino, M., Sasaki, D., Abe, J., & Harashima, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.010 · Cited by 129
Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS‐CoV‐2 ‘long‐haulers’?
Wood, E., Hall, K., & Tate, W. P. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.11.002 · Cited by 132
Mitochondria-targeted therapeutics, MitoQ and BGP-15, reverse aging-associated meiotic spindle defects in mouse and human oocytes
Al-Zubaidi, U., Adhikari, D., Çınar, Ö., Zhang, Q.-H., Yuen, W. S., Murphy, M. P., Rombauts, L. J. F., Robker, R. L., & Carroll, J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa300 · Cited by 124
Self-citation
Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening
Canugovi, C., Stevenson, M., Vendrov, A. E., Hayami, T., Robidoux, J., Xiao, H., Zhang, Y., Eitzman, D. T., Runge, M. S., & Madamanchi, N. R. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101288 · Cited by 126
Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix
Brand, M. D. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828258 · Cited by 123
Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far
McElwain, C. J., McCarthy, F. P., & McCarthy, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084261 · Cited by 134
Mitochondrial Regulation of Stem Cells in Bone Homeostasis
Zheng, C., Sui, B., Qiu, X., Hu, C., & Jin, Y. J. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.008 · Cited by 121
SIRT1 prevents cigarette smoking-induced lung fibroblasts activation by regulating mitochondrial oxidative stress and lipid metabolism
Zhang, Y., Li, T., Pan, M., Wang, W., Huang, W., Yuan, Y., Xie, Z., Chen, Y., Peng, J., Li, X., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03408-5 · Cited by 120
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Xu, H., Li, S., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01082-z · Cited by 130
Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications
Manolis, A. S., Manolis, A. A., Manolis, T. A., Apostolaki, N. E., Apostolopoulos, E. J., Melita, H., & Katsiki, N. (2020) · Medicinal Research Reviews · doi:10.1002/med.21732 · Cited by 116
Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review
Fujimoto, C., & Yamasoba, T. (2019) · Antioxidants · doi:10.3390/antiox8040109 · Cited by 109
Gut Microbiome-Derived Metabolite Trimethylamine N-Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans
Brunt, V. E., Casso, A. G., Gioscia‐Ryan, R. A., Sapinsley, Z. J., Ziemba, B. P., Clayton, Z. S., Bazzoni, A. E., VanDongen, N. S., Richey, J. J., Hutton, D. A., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16895 · Cited by 111
Self-citation
Systemic Aging Fuels Heart Failure: Molecular Mechanisms and Therapeutic Avenues
Fang, Z., Raza, U., Song, J., Lu, J., Yao, S., Liu, X., Zhang, W., & Li, S. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14947 · Cited by 117
Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment
Yang, J., Guo, Q., Feng, X., Liu, Y., & Zhou, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841523 · Cited by 105
The mitochondria-targeted antioxidant MitoQ, attenuates exercise-induced mitochondrial DNA damage
Williamson, J., Hughes, C., Cobley, J. N., & Davison, G. W. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101673 · Cited by 103
Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects
Strong, R., Miller, R. A., Bogue, M., Fernandez, E., Javors, M. A., Libert, S., Marinez, P. A., Murphy, M. P., Musi, N., Nelson, J. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13269 · Cited by 92
Self-citation
Triphenylphosphonium (TPP)‐Based Antioxidants: A New Perspective on Antioxidant Design
Wang, J., Li, J. Q., Xiao, Y., Fu, B., & Qin, Z. (2020) · ChemMedChem · doi:10.1002/cmdc.201900695 · Cited by 103
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease
Camacho-Encina, M., Booth, L. K., Redgrave, R. E., Folaranmi, O., Spyridopoulos, I., & Richardson, G. D. (2024) · Cells · doi:10.3390/cells13040353 · Cited by 103
Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents
Huang, M., Myers, C. R., Wang, Y., & You, M. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0425 · Cited by 99
Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
Fortner, K. A., Blanco, L. P., Buskiewicz, I. A., Huang, N., Gibson, P. C., Cook, D. L., Pedersen, H. L., Yuen, P. S. T., Murphy, M. P., Perl, A., et al. (2020) · Lupus Science & Medicine · doi:10.1136/lupus-2020-000387 · Cited by 94
Self-citation
The mitochondria-targeted antioxidant MitoQ attenuated PM2.5-induced vascular fibrosis via regulating mitophagy
Ning, R., Li, Y., Du, Z., Li, T., Sun, Q., Lin, L., Xu, Q., Duan, J., & Sun, Z. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102113 · Cited by 96
“decreased aortic stiffness after 6 weeks of oral MitoQ (20 mg/d), which was expected to treat vascular dysfunction caused by ageing [29].”
Drug Development for the Therapy of Mitochondrial Diseases
Weissig, V. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.002 · Cited by 95
Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease
Park, S., Pekas, E. J., Headid, R. J., Son, W., Wooden, T. K., Song, J., Layec, G., Yadav, S. K., Mishra, P. K., & Pipinos, I. I. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00235.2020 · Cited by 91
Coenzyme Q10 Analogues: Benefits and Challenges for Therapeutics
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Munuera-Cabeza, M., Suárez-Carrillo, A., Talaverón-Rey, M., & Sánchez-Alcázar, J. A. (2021) · Antioxidants · doi:10.3390/antiox10020236 · Cited by 98
Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging
Szeto, H. H., & Liu, S. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.10.013 · Cited by 89
Mitoquinone attenuates vascular calcification by suppressing oxidative stress and reducing apoptosis of vascular smooth muscle cells via the Keap1/Nrf2 pathway
Cui, L., Zhou, Q., Zheng, X., Sun, B., & Zhao, S. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.09.028 · Cited by 88
Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway
Chen, Z., Yu, J., Fu, M., Dong, R., Yang, Y., Luo, J., Hu, S., Li, W., Xu, X., & Tu, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113951 · Cited by 85
Systemic effects of mitochondrial stress
Bar‐Ziv, R., Bolas, T., & Dillin, A. G. (2020) · EMBO Reports · doi:10.15252/embr.202050094 · Cited by 86
Hypoxia and Mitochondrial Dysfunction in Pregnancy Complications
Hu, X., & Zhang, L. (2021) · Antioxidants · doi:10.3390/antiox10030405 · Cited by 93
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Alshial, E. E., Abdulghaney, M. I., Wadan, A. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122257 · Cited by 91
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 88
Healthy lifestyle-based approaches for successful vascular aging
Rossman, M. J., LaRocca, T. J., Martens, C. R., & Seals, D. R. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00521.2018 · Cited by 85
Self-citation
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment
Clayton, Z. S., Brunt, V. E., Hutton, D. A., VanDongen, N. S., D’Alessandro, A., Reisz, J. A., Ziemba, B. P., & Seals, D. R. (2020) · JACC CardioOncology · doi:10.1016/j.jaccao.2020.06.010 · Cited by 90
Self-citation
Mitochondrial Dysfunction: Cause or Consequence of Vascular Calcification?
Phadwal, K., Vrahnas, C., Ganley, I. G., & MacRae, V. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.611922 · Cited by 86
Mitochondrial Dysfunction in Cardiovascular Diseases
Yang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051917 · Cited by 91
Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
Bottani, E., Lamperti, C., Prigione, A., Tiranti, V., Persico, N., & Brunetti, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111083 · Cited by 89
Mitochondrial quality control in health and cardiovascular diseases
Atici, A. E., Crother, T. R., & Rivas, M. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1290046 · Cited by 85
Altered Intracellular Calcium Homeostasis and Arrhythmogenesis in the Aged Heart
Hamilton, S., & Terentyev, D. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102386 · Cited by 82
Oxidative Stress, Mitochondrial Function and Adaptation to Exercise: New Perspectives in Nutrition
Vargas-Mendoza, N., Ángeles-Valencia, M., Morales‐González, Á., Madrigal‐Santillán, E., Morales-Martínez, M., Madrigal‐Bujaidar, E., Álvarez‐González, I., Gutiérrez‐Salinas, J., Esquivel-Chirino, C., Chamorro, G., et al. (2021) · Life · doi:10.3390/life11111269 · Cited by 88
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress
Roy, B. (2025) · Medical Sciences · doi:10.3390/medsci13030087 · Cited by 103
Mitochondrial superoxide/hydrogen peroxide: An emerging therapeutic target for metabolic diseases
Yan, J., Jiang, J., He, L., & Chen, L. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.029 · Cited by 78
Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
Ciccarelli, G., Conte, S., Cimmino, G., Maiorano, P., Morrione, A., & Giordano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021086 · Cited by 75
Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies
Hu, M., Bogoyevitch, M. A., & Jans, D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00030.2019 · Cited by 72
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 78
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer’s Disease
Guha, S. K., Johnson, G. V. W., & Nehrke, K. W. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02084-0 · Cited by 77
The role of reactive oxygen species in bone cell physiology and pathophysiology
Marques-Carvalho, A., Kim, H., & Almeida, M. (2023) · Bone Reports · doi:10.1016/j.bonr.2023.101664 · Cited by 80
Overexpression of catalase targeted to mitochondria improves neurovascular coupling responses in aged mice
Csiszár, A., Yabluchanskiy, A., Ungvari, A., Ungvari, Z. I., & Tarantini, S. (2019) · GeroScience · doi:10.1007/s11357-019-00111-0 · Cited by 69
Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm
Wang, Y., Ge, M., Wang, J., Xu, Y., Wang, N., & Xu, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08114-w · Cited by 83
Advancements in therapeutic drugs targeting of senescence
Zhu, M., Meng, P., Ling, X., & Zhou, L. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320964125 · Cited by 68
Aging of the Arterial System
Castelli, R., Gidaro, A., Casu, G., Merella, P., Profili, N. I., Donadoni, M., Maioli, M., & Delitala, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086910 · Cited by 79
Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
Bhatti, G. K., Gupta, A., Pahwa, P., Khullar, N., Singh, S., Navik, U., Kumar, S., Mastana, S. S., Reddy, A. P., Reddy, P. H., et al. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.002 · Cited by 66
The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia–reperfusion injury by enhancing PINK1/Parkin-mediated mitophagy in type 2 diabetic rats
Ji, Y., Leng, Y., Lei, S., Qiu, Z., Ming, H., Zhang, Y., Zhang, A., Wu, Y., & Xia, Z. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01273-1 · Cited by 64
Protective role of mitoquinone against impaired mitochondrial homeostasis in metabolic syndrome
Yang, J., Suo, H., & Song, J. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1809344 · Cited by 65
Mitochondria-Targeted Drug Delivery in Cardiovascular Disease: A Long Road to Nano-Cardio Medicine
Forini, F., Canale, P., Nicolini, G., & Iervasi, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111122 · Cited by 63
Mitochondria in Alzheimer’s Disease Pathogenesis
Reiss, A. B., Gulkarov, S., Jacob, B., Srivastava, A., Pinkhasov, A., Gomolin, I. H., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2024) · Life · doi:10.3390/life14020196 · Cited by 71
Oxidative Stress and Inflammation Are Associated With Age-Related Endothelial Dysfunction in Men With Low Testosterone
Babcock, M. C., DuBose, L. E., Witten, T. L., Stauffer, B. L., Hildreth, K. L., Schwartz, R. S., Kohrt, W. M., & Moreau, K. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab715 · Cited by 64
Is It Good to Have a Stiff Aorta with Aging? Causes and Consequences
Pierce, G. L., Coutinho, T. A., DuBose, L. E., & Donato, A. J. (2021) · Physiology · doi:10.1152/physiol.00035.2021 · Cited by 64
Chronic hyperglycemia and cardiovascular dysfunction: an in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus
Hussain, A. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00247-3 · Cited by 84
Mitochondria-Targeted Antioxidants and Skeletal Muscle Function
Broome, S. C., Woodhead, J. S. T., & Merry, T. L. (2018) · Antioxidants · doi:10.3390/antiox7080107 · Cited by 64
Redox signaling in heart failure and therapeutic implications
Weissman, D., & Maack, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.013 · Cited by 60
MitoQ alleviates hippocampal damage after cerebral ischemia: The potential role of SIRT6 in regulating mitochondrial dysfunction and neuroinflammation
Ibrahim, A. A., Mageed, S. S. A., Safar, M. M., El-Yamany, M. F., & Oraby, M. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121895 · Cited by 60
Mitochondria orchestrate macrophage effector functions in atherosclerosis
Dumont, A., Lee, M., Barouillet, T., Murphy, A. J., & Yvan‐Charvet, L. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100922 · Cited by 60
Mitochondria as Therapeutic Targets in Heart Failure
Schwemmlein, J., Maack, C., & Bertero, E. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00539-0 · Cited by 59
The Role of Lifestyle and Dietary Factors in the Development of Premature Ovarian Insufficiency
Shelling, A. N., & Nasef, N. A. (2023) · Antioxidants · doi:10.3390/antiox12081601 · Cited by 63
Mitochondrial regulation of diabetic vascular disease: an emerging opportunity
Widlansky, M. E., & Hill, R. B. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.015 · Cited by 58
Subversion of Host Cell Mitochondria by RSV to Favor Virus Production is Dependent on Inhibition of Mitochondrial Complex I and ROS Generation
Hu, M., Bogoyevitch, M. A., & Jans, D. A. (2019) · Cells · doi:10.3390/cells8111417 · Cited by 57

Authors: Rossman, M. J., Santos-Parker, J. R., Steward, C. A. C., Bispham, N. Z., Cuevas, L. M., Rosenberg, H. L., Woodward, K. A., Chonchol, M., Gioscia-Ryan, R. A., Murphy, M. P., & Seals, D. R.
Affiliations: University of Colorado Boulder (US)
From the Department of Integrative Physiology, University of Colorado Boulder (M.J.R., J.R.S.-P., C.A.C.S., N.Z.B., L.M.C., H.L.R., K.A.W., R.A.G.-R., D.R.S.)
University of Colorado Anschutz (US)
MRC Mitochondrial Biology Unit (GB)
ORCID: Rossman, Matthew J.
Bispham, Nina Z.
Rosenberg, Hannah L.
Woodward, Kayla A.
Chonchol, Michel
Murphy, Michael P.
Seals, Douglas R.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2018-06
Volume: 71
Issue: 6
Pages: 1056-1063
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/hypertensionaha.117.10787
PMC: PMC5945293
OpenAlex: W2796629168
Cited by: 456
References: 42
Citations by year: 2026: 71 · 2025: 48 · 2024: 55 · 2023: 54 · 2022: 65 · 2021: 54 · 2020: 58 · 2019: 38 · 2018: 12
FWCI: 30.51
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Apollo (University of Cambridge) (submittedVersion)
Apollo
Funders: Wellcome Trust (110158/Z/15/Z, 110159/Z/ 15/Z, /Z/15/Z)
Georgia Clinical and Translational Science Alliance (UL1TR001082)
National Institutes of Health (UL1TR001082, AG000279)
University of Colorado Boulder (UL1 TR001082)
Medical Research Council (MC_UU_00015/3, MC-U105663142)
National Institute on Aging (R21AG049451, F32AG053009, T32AG000279)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK048520)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords: MitoQ, mitochondria-targeted antioxidants, mitochondrial reactive oxygen species, endothelial function, flow-mediated dilation, arterial stiffness, pulse wave velocity, oxidative stress, oxidized LDL, aging, older adults, vascular dysfunction, dietary supplementation
MeSH terms: Aged, Antioxidants, Brachial Artery, Double-Blind Method, Endothelium, Vascular, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mitochondria, Vasodilation, Reactive Oxygen Species, Oxidative Stress, Cross-Over Studies, Dietary Supplements, Vascular Stiffness, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks